R Havlík

791 total citations
46 papers, 621 citations indexed

About

R Havlík is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, R Havlík has authored 46 papers receiving a total of 621 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Oncology, 18 papers in Surgery and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in R Havlík's work include Pancreatic and Hepatic Oncology Research (17 papers), Virus-based gene therapy research (9 papers) and Cancer Research and Treatments (6 papers). R Havlík is often cited by papers focused on Pancreatic and Hepatic Oncology Research (17 papers), Virus-based gene therapy research (9 papers) and Cancer Research and Treatments (6 papers). R Havlík collaborates with scholars based in Czechia, United Kingdom and United States. R Havlík's co-authors include Nagy Habib, Ragai R. Mitry, Catherine Sarraf, Joanna P. Nicholls, S L Jensen, Martin Köcher, Hosny Salama, Vladimı́r Král, Martin Loveček and Marie Černá and has published in prestigious journals such as Hepatology, Biochemical Pharmacology and World Journal of Gastroenterology.

In The Last Decade

R Havlík

45 papers receiving 611 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R Havlík Czechia 11 300 222 221 183 136 46 621
E. Hagmüller Germany 12 254 0.8× 123 0.6× 162 0.7× 238 1.3× 131 1.0× 35 800
Biao Nie China 11 244 0.8× 262 1.2× 243 1.1× 202 1.1× 64 0.5× 20 785
Khoi Q. Tran United States 10 861 2.9× 112 0.5× 194 0.9× 237 1.3× 236 1.7× 15 1.2k
Ioannis D. Kostakis Greece 10 197 0.7× 62 0.3× 239 1.1× 95 0.5× 107 0.8× 14 530
Vittorio Albino Italy 17 197 0.7× 71 0.3× 125 0.6× 121 0.7× 115 0.8× 43 758
Semyon A. Risin United States 9 217 0.7× 43 0.2× 203 0.9× 57 0.3× 99 0.7× 25 564
Laurie P. Peiffer United States 12 133 0.4× 61 0.3× 160 0.7× 96 0.5× 65 0.5× 24 436
Rocky L.K. Ho Hong Kong 13 212 0.7× 38 0.2× 280 1.3× 146 0.8× 97 0.7× 16 677
Dongdong Lin China 12 124 0.4× 51 0.2× 179 0.8× 102 0.6× 69 0.5× 43 512
Jonathan Evans United Kingdom 7 156 0.5× 72 0.3× 109 0.5× 59 0.3× 47 0.3× 12 355

Countries citing papers authored by R Havlík

Since Specialization
Citations

This map shows the geographic impact of R Havlík's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R Havlík with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R Havlík more than expected).

Fields of papers citing papers by R Havlík

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R Havlík. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R Havlík. The network helps show where R Havlík may publish in the future.

Co-authorship network of co-authors of R Havlík

This figure shows the co-authorship network connecting the top 25 collaborators of R Havlík. A scholar is included among the top collaborators of R Havlík based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R Havlík. R Havlík is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Janek, Jürgen, Zdenka Fohlerová, David Panáček, et al.. (2025). A label-free impedimetric immunosensor based on nitrogen-doped graphene acid for sensitive detection of vitamin D3. Microchimica Acta. 192(12). 823–823. 1 indexed citations
2.
Loveček, Martin, Markéta Janatová, Pavel Skalický, et al.. (2019). Genetic analysis of subsequent second primary malignant neoplasms in long-term pancreatic cancer survivors suggests new potential hereditary genetic alterations. Cancer Management and Research. Volume 11. 599–609. 4 indexed citations
3.
Loveček, Martin, Pavel Skalický, Mininder S. Kocher, et al.. (2017). [Postpancreatectomy haemorrhage (PPH), prevalence, diagnosis and management].. PubMed. 95(9). 350–357. 7 indexed citations
4.
Melichar, Bohuslav, Hana Študentová, Lenka Kujovská Krčmová, et al.. (2016). Association of urinary neopterin, neutrophil-to-lymphocyte, lymphocyte-to-monocyte and platelet-to-lymphocyte ratios with long-term survival of patients with breast cancer. Pteridines. 27(3-4). 59–65. 3 indexed citations
5.
Loveček, Martin, et al.. (2016). Emergency surgical treatment of complicated acute pancreatitis after kidney transplantation with acute rejection: Case report and literature review. Annals of Medicine and Surgery. 8. 14–17. 2 indexed citations
6.
Loveček, Martin, Pavel Skalický, Č Neoral, et al.. (2015). [Surgical therapy of pancreatic cancer - 5 years survival].. PubMed. 94(11). 470–6. 2 indexed citations
7.
Srovnal, Josef, Pavel Skalický, Jana Vrbková, et al.. (2015). [Determination of CEA, EGFR and hTERT expression in peritoneal lavage in patients with pancreatic adenocarcinoma using RT - PCR method].. PubMed. 94(11). 464–9; discussion 469. 6 indexed citations
8.
Novotný, Radko, et al.. (2013). Mitochondrial Changes in Adenocarcinoma of the Pancreas. Ultrastructural Pathology. 37(3). 227–231. 6 indexed citations
9.
Havlík, R, et al.. (2012). Occult tumour cells in peritoneal lavage are a negative prognostic factor in pancreatic cancer. Biomedical Papers. 157(3). 233–238. 6 indexed citations
10.
Thomas, Rohit Philip, et al.. (2009). IS THE BILIARY MANOMETRIC PERFUSION TEST EFFECTIVE IN THE EVALUATION OF BALLOON DILATATION TREATMENT SUCCESS OF BENIGN BILIARY STRICTURES?. Biomedical Papers. 153(2). 153–156. 1 indexed citations
11.
Köcher, Martin, et al.. (2008). BILIARY MANOMETRIC PERFUSION TEST IN THE EVALUATION OF BENIGN BILIARY STRICTURE TREATMENT - A CASE REPORT. Biomedical Papers. 152(2). 293–297. 2 indexed citations
12.
Habib, Nagy, R Havlík, Long Jiao, et al.. (2004). Combination of optison with ultrasound and electroporation increases albumin and thrompoietin transgene expression whilst elongation factor promoter prolongs its duration. WestminsterResearch (University of Westminster). 3 indexed citations
13.
Jiao, Long R., R Havlík, Joanna P. Nicholls, S L Jensen, & Nagy Habib. (2004). Suicide Gene Therapy in Liver Tumors. Humana Press eBooks. 90. 433–450. 4 indexed citations
14.
Habib, Nagy, Hosny Salama, Catherine Sarraf, et al.. (2002). Clinical trial of E1B-deleted adenovirus (dl1520) gene therapy for hepatocellular carcinoma. Cancer Gene Therapy. 9(3). 254–259. 93 indexed citations
15.
Neoral, Č, et al.. (2002). [Role of modern absorbable suture materials in decreasing the occurrence of early complications after laparotomy].. PubMed. 81 Suppl 1. S24–6. 1 indexed citations
16.
Habib, Nagy, Ragai R. Mitry, Catherine Sarraf, et al.. (2002). Assessment of growth inhibition and morphological changes in in vitro and in vivo hepatocellular carcinoma models post treatment with dl1520 adenovirus. Cancer Gene Therapy. 9(5). 414–420. 24 indexed citations
17.
Havlík, R, et al.. (2001). Intravascular Micropump for Augmented Liver Perfusion: First In Vivo Experience. Artificial Organs. 25(5). 392–394. 8 indexed citations
18.
Havlík, R, et al.. (2000). Measurement of Hepatic Tissue Hypoxia Using Near Infrared Spectroscopy: Comparison with Hepatic Vein Oxygen Partial Pressure. European Surgical Research. 32(4). 207–214. 27 indexed citations
19.
Mitry, Ragai R., Catherine Sarraf, R Havlík, & Nagy Habib. (2000). Detection of adenovirus and initiation of apoptosis in hepatocellular carcinoma cells after ad- p53 treatment. Hepatology. 31(4). 885–889. 40 indexed citations
20.
Havlík, R, et al.. (1999). [Can mechanical augmentation of portal vein flow be an alternative treatment for portal hypertension and liver failure?].. PubMed. 78(9). 461–4. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026